You are here

AusPAR: Mogamulizumab

Australian Public Assessment Report

10 May 2021
AusPAR Details
AusPAR
Active Ingredient
Mogamulizumab
Product Name
Poteligeo
Sponsor
Kyowa Kirin Australia Pty Ltd
Submission Number
PM-2020-00700-1-6
Submission Type
New biological entity
Decision
Approved
AusPAR Date
27 April 2021
Publication Date

10 May 2021